Back to feed
S. 2033
In Committee
Rider
92%won't pass
Drug Pricing Reform
Pharmaceutical Pricing Transparency and Competition Act
Sponsor: Sen. Bernie Sanders (I)12 cosponsors
Healthcare
Pharmaceuticals
1Passage Analysis
bipartisan
No
reintroduction
Yes
committee position
unfavorable
majority party sponsor
No
~7% of bills become law. Low passage odds are normal and expected. Model based on structural factors only; does not use trading data.
2Who is Positioned
NP
Nancy Pelosi
Rep. (D-CA)sell$300K
Recent Trades in Affected Tickers
No recent trades in affected tickers.